Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biosimilar teriparatide versus alendronate for fracture prevention in older women with osteoporosis at imminent fracture risk
2020-005712-22Phase 4Active
- Sponsor
- Gedeon Richter Plc
- Start
- Jun 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in postmenopausal osteoporosis and fragility fracture comparing Biosimilar teriparatide with Alendronate (2 arms). Started Jun 2021; status: active.
02
Drugs
teriparatidealendronate
03
Conditions
postmenopausal osteoporosisfragility fracture
Beyond the preview
Go deeper on 2020-005712-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005712-22.